Our Clinical Trials

Patient needs are what drive us to innovate.

Arthex Clinical Trial

About Arthex Biotech

Arthex Biotech is a biotechnology company developing new treatments for diseases without many treatment options.

Arthex Biotech is running a clinical trial of an experimental medication called ATX-01 in participants with myotonic dystrophy type 1 (DM1).

The trial is called the ArthemiRTM trial.

Where is the study being conducted?

In specialist DM1 centers in USA and other countries.
Check back soon for details on the study and where the study centers are located.